Appendix Table 4.

Secondary Binary Study Outcomes: Model-Based Proportions and Associated 95% CIs, by Treatment Group and Time Point^*

Outcome	Usual Care			CBT
	Proportion	95% CI		Proportion	95% CI
		LB	UB		LB	UB
Benzodiazepine receipt
Baseline	0.220	0.184	0.255	0.236	0.199	0.273
3-mo follow-up	0.229	0.195	0.263	0.218	0.185	0.251
6-mo follow-up	0.226	0.195	0.256	0.206	0.178	0.234
9-mo follow-up	0.227	0.195	0.258	0.197	0.168	0.227
12-mo follow-up	0.229	0.193	0.264	0.190	0.157	0.222
Continued long-term opioid therapy
Baseline	0.767	0.722	0.813	0.763	0.719	0.806
3-mo follow-up	0.722	0.677	0.767	0.696	0.651	0.740
6-mo follow-up	0.715	0.672	0.757	0.692	0.650	0.733
9-mo follow-up	0.700	0.657	0.744	0.681	0.638	0.724
12-mo follow-up	0.683	0.636	0.729	0.668	0.622	0.713
Average daily dose of opioids ≥90 MME
Baseline	0.253	0.234	0.273	0.173	0.153	0.192
3-mo follow-up	0.266	0.252	0.280	0.175	0.160	0.191
6-mo follow-up	0.256	0.241	0.270	0.162	0.147	0.178
9-mo follow-up	0.247	0.230	0.265	0.151	0.134	0.168
12-mo follow-up	0.241	0.218	0.264	0.143	0.122	0.164

CBT = cognitive behavioral therapy; LB = lower bound; MME = morphine milligram equivalents; UB = upper bound.

^*Proportions are based on mixed model logistic regression equation.